“You are an NPD expert. Guide me on how to quickly launch a cosmetic range that is scientifically proven, clean, hormone balanced with no harmful ingredients.”
That’s the kind of prompt that opens an AI Pandora’s box. Ask it, and you’ll get a tidy roadmap: trending actives, a generic timeline, a shortlist of contract manufacturers. What AI gives you is information, but with a split formula, the wrong packaging sample, or a contract manufacturer negotiation, it’s years of doing this and troubleshooting along the way that get a product to market successfully. Here are the few steps I always remind everyone in the team to keep in mind along the way:
Start with the brief, not the actives
AI will happily list you the trendy actives and their inclusion levels. However, your formula’s clinical performance doesn’t depend on the hero active alone, all the ingredients contribute to efficacy, stability and sensory performance. To get it right, apart from actives, you must choose the right emollient mix, the emulsifiers, the humectants and the solvents.
Before you start on the INCI, firm up three things that will lead your formulation:
- Rare ingredients and MQO. They can look amazing on the technical sheet, but pay attention to shelf life, how the MQO compares to your inclusion level, and how reliably the supply chain will perform, batch after batch.
- Where you’re launching. UK plus EU, US, or the rest of the world too? Each region carries its own restricted and permitted ingredient lists, claims rules and documentation requirements. Retrofitting a formula or a pack for a second market later can be expensive and slow.
- What you’re packing it in, is it a pump, jar or a tube. Packaging shapes the visual identity of your brand, but it also drives your viscosity range and compatibility requirements and can rule out certain actives entirely. It comes first, not last.
Finding a CDMO: this is where it gets tricky
AI defaults to the loudest, most SEO-friendly CDMOs. They’re often the ones with the biggest minimum order quantities, which is exactly wrong for a first range.
Every contract manufacturer will hand you their standard T&Cs. Read them and push back. Ask, specifically:
- Who owns the formula, and what do you need to do to own it?
- Will they notify you of every raw material or supplier change, and update your Product Information File accordingly?
- Will you be able to tech-transfer easily if you need to move manufacturer later?
- What are the payment terms, lead times, and how often will they update pricing?
- What’s chargeable that isn’t obvious upfront, annexes, regulatory admin, minor artwork tweaks?
- Do they hold the relevant certifications, GMP and ISO 22716 as a minimum?
These manufacturers have seen every “innovative” pitch before. They will negotiate to protect themselves, so should you.
Packaging: source it yourself
I always source packaging independently; through suppliers I already trust to find what I need.
A few things to hold onto:
- Colour tolerance boards, since batch-to-batch colour will drift and tolerance needs agreeing in advance, in writing.
- Innovative shapes come with high MQOs and, often, unreliable supply chains and production issues. Plastic packaging can start to degrade if not stored properly for longer periods, so don’t tie your money up in bottles rotting in a warehouse.
Artwork is a minefield
Regulatory will check your claims against what you can substantiate, and against the mandatory information a pack legally requires. But it’s your responsibility to check spelling, grammar and the barcode, and never sign off artwork proofs without checking.
GMP means owning the process
GMP asks for multiple layers of control, and although manufacturers run their own, make sure you are involved at the critical points of approval, that’s the only way you catch problems before they reach a customer. Approve every bulk, every finished-product run, and every new pack, label or carton. Creating a check list helps avoid mistakes when things become repetitive.
Testing takes the time it takes
Build your timeline around real testing durations, and run what you can in parallel: stability, 3 months; compatibility, 3 months; microbial challenge, 4 weeks, plus time for the report to be issued.
Scale-up is where “lovely in a beaker” gets tested
Purchase orders are normally placed once testing has passed, though some brands place them 8 weeks earlier if they’re willing to accept the risk of committing before stability data are finalised. For anything technically ambitious, like a bouncy mousse concealer with a novel ingredient system, insist on a scale-up trial before committing to full production. It can look flawless at bench scale and behave completely differently in a 150kg vessel. This step gets skipped under time pressure, but it can become very expensive when it fails.
Regulatory paperwork has its own clock
Most contract manufacturers need four to six weeks to release the full PIF and safety reports. You cannot list a product with any retailer without the full INCI breakdown, Safety Data Sheet, and, often, a COA and notifications on CPNP and SCPN for EU and UK.
Build this into your critical path early, so it doesn’t come as a surprise at the end.
Production is a live thing
Machines break down, micro samples get lost in the post, so make sure build a couple of weeks’ buffer into your stock-in-warehouse dates, even once production and dispatch dates feel firm.
The honest version
Nine months is achievable, even six sometimes, but only if the brief, the region, the pack format and the manufacturer contract are settled early, and you have someone whose instinct based on years of experience will tell you when the innovative pitch is about to become a scale-up disaster or the brand’s next hero. AI can give you the map, but you have to walk the road to know what to expect along the way.
